- Main
Effect of liposomal bupivacaine for preoperative erector spinae plane block on postoperative pain following video-assisted thoracoscopic lung resection: a multicenter, randomized, double-blind, clinical trial.
- Shan, Xi-Sheng;
- Liao, Da-Wei;
- Guo, Jian;
- Xia, Zhong-Yuan;
- Lv, Xin;
- Shen, Jiang;
- Tong, Jian-Hua;
- Wei, Fu-Jiang;
- Li, Xiao-Shuang;
- Qu, Xian-Feng;
- Wang, Xiao-Bin;
- Wang, Ying-Bin;
- Ou, Shan-Shan;
- Yang, Yu-Fan;
- Meng, Lingzhong;
- Liu, Hong;
- Peng, Ke;
- Ji, Fu-Hai
Published Web Location
https://doi.org/10.1097/js9.0000000000003956Abstract
BACKGROUND: The effectiveness of liposomal bupivacaine for postoperative analgesia in thoracoscopic surgery remains uncertain. We assessed liposomal bupivacaine for erector spinae plane block (ESPB) on pain control after video-assisted thoracoscopic lung resection. MATERIALS AND METHODS: In this multicenter, randomized controlled trial, 272 adults were randomly assigned (1:1) to receive either liposomal bupivacaine or bupivacaine hydrochloride for preoperative ultrasound-guided ESPB. The primary outcome was the cumulative numeric rating scale pain score at rest (area under the curve during 0-72 hours postoperatively). Secondary outcomes included 72-hour cumulative activity pain, time to first patient-controlled analgesia, total opioid consumption within 72 hours, pain scores at multiple postoperative time points, recovery quality at 72 hours, and activity pain at 14 days and 3 months. RESULTS: A total of 267 patients were analysed (median age, 58 years; women, 64.8%). The 72-hour cumulative rest pain was significantly lower in the liposomal bupivacaine group (205.0 vs 232.5; difference,-26.5; 95% CI,-35.5 to-17.5; P<0.001) but did not reach the minimal clinically important difference of 72 (predefined) or 42 (anchor-based). Pain scores at 24 and 32 hours, both at rest and during activity, achieved the clinically important difference of 1. Liposomal bupivacaine was associated with lower opioid consumption and higher recovery quality. The other outcomes did not differ between groups. CONCLUSIONS: Among patients undergoing video-assisted thoracoscopic lung resection, liposomal bupivacaine for ESPB led to a statistically significant reduction in 72-hour cumulative rest pain compared with bupivacaine hydrochloride. Pain relief at 24 and 32 hours met the predefined threshold for clinical significance.
Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.